Free Trial

Windtree Therapeutics (WINT) Earnings Date, Estimates & Call Transcripts

Windtree Therapeutics logo
$0.10 -0.01 (-5.02%)
As of 03:58 PM Eastern

Windtree Therapeutics Earnings Summary

Windtree Therapeutics released Q2 2025 earnings on August 19, 2025, reporting an EPS of -$3.06, which topped analysts' consensus estimates of -$99.00 by $95.94. With a trailing EPS of -$823.47, Windtree Therapeutics' earnings are expected to grow next year, from ($5.66) to ($2.86) per share.

Latest Q2
Earnings Date
Aug. 19Estimated
Consensus EPS
(Aug. 19)
-$99.00
Actual EPS
(Aug. 19)
-$3.06 Beat By $95.94
Get Windtree Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Windtree Therapeutics and other key companies, straight to your inbox.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

WINT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Windtree Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($5.66) EPS
Next Year EPS Consensus Estimate
($2.86) EPS

Windtree Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/19/2025Q2 2025-$99.00-$3.06+$95.94-$3.06$3.00M-
5/15/2025Q1 2025-$39.00-$4.63+$34.37-$4.63$2.20M-
11/26/2024Q3 2024-$113.50-$211.50 -$98.00-$4.23--
8/19/2024--$405.50-$1,045.50 -$640.00-$20.91--
5/15/2024Q4 2023--$462.50--$40.48--
4/16/2024Q4 2023--$665.50--$13.31--
11/9/2023Q3 2023--$774.00--$0.86--

Windtree Therapeutics Earnings - Frequently Asked Questions

Windtree Therapeutics (NASDAQ:WINT) last announced its quarterly earning data on Tuesday, August 19, 2025. Learn more on WINT's earnings history.

In the previous quarter, Windtree Therapeutics (NASDAQ:WINT) reported ($3.06) earnings per share (EPS) to beat the analysts' consensus estimate of ($99.00) by $95.94. Learn more on analysts' earnings estimate vs. WINT's actual earnings.

Windtree Therapeutics (NASDAQ:WINT) has a recorded net income of -$1.79 million. WINT has generated -$823.47 earnings per share over the last four quarters.

Windtree Therapeutics' earnings are expected to grow from ($5.66) per share to ($2.86) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:WINT) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners